FdaApplication
NDA 203975
Identifiers
- fda_app_no: NDA203975
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND |
| application_type | NDA |
| approval_date | 2013-12-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANORO ELLIPTA | UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH | POWDER;INHALATION |
1 product